Scrip Dividend - calculation price

Reading, United Kingdom (9 September 2021)

On 30 July 2021, the Board of Directors of ConvaTec Group Plc ("ConvaTec" or "the Company") declared an interim dividend of 1.717 cents per share ("Interim Dividend"). This Interim Dividend is to be paid on 14 October 2021 to shareholders on the share register as of 3 September 2021 ("Record Date"). The Interim Dividend is payable in cash, in sterling to holders of ordinary shares. The chosen exchange rate for this payment is $1.397/£1.00, determined on 29 July 2021, giving a total sterling dividend of £24,749,881. A scrip dividend will be made available for this Interim Dividend, allowing shareholders to elect to receive their dividend in the form of new ordinary shares.

The "Calculation Price" for the issue of new ordinary shares under the scrip dividend scheme is:

226.08 pence for each new ordinary share.

This is equivalent to 1 new share for approximately 183.95 shares held prior to the ex-dividend date of 2 September 2021.

The Calculation Price is the average of the middle market quotations of a ConvaTec share, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 2 September to 8 September 2021 (inclusive).

The latest date for receipt of elections to participate in the scrip dividend scheme for the Interim Dividend is 21 September 2021. Shareholders must return their mandate form by 5pm (BST) or otherwise input their CREST elections to be received by the Company's registrar, Computershare, by 3pm (BST) on 21 September 2021. Elections received after this deadline will apply to subsequent dividends only. Unless revoked by you, your scrip dividend election will apply for all future dividends for which a scrip dividend is offered. Evergreen elections for CREST shareholders cannot be accepted and elections will revert to cash by default after the payment of each dividend.

Details of the scrip dividend scheme are available at www.convatecgroup.com/investors.

TIMETABLE

Key dates in respect of the scrip dividend scheme for the Interim Dividend are:

Rules and share certificates, CREST accounts credited/updated,

and first day of dealings in New Shares

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations

& Corporate Communications                                                    +44 (0)782 644 7807

ir@convatec.com

Media

Buchanan: Charles Ryland / Chris Lane                                    +44 (0)207 466 5000                                                                                                 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com.

# # #

END